{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T23:56:22Z","timestamp":1783814182071,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012297","name":"Society of Family Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.contraception.2019.05.006","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T01:58:07Z","timestamp":1557971887000},"page":"178-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Medical abortion with mifepristone and vaginal misoprostol between 64 and 70\u202fdays' gestation"],"prefix":"10.1016","volume":"100","author":[{"given":"Jennifer K","family":"Hsia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A","family":"Lohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell D","family":"Creinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2019.05.006_bb0005","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1001\/jama.284.15.1948","article-title":"Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial","volume":"284","author":"Schaff","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2019.05.006_bb0010","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/01.AOG.0000258298.35143.d2","article-title":"Mifepristone and misoprostol administered simultaneously compared with 24 hours apart for abortion","volume":"109","author":"Creinin","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2019.05.006_bb0015","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/01.AOG.0000124271.23499.84","article-title":"MOD study trial group. A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion","volume":"103","author":"Creinin","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2019.05.006_bb0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/AOG.0000000000000897","article-title":"Mifepristone with buccal misoprostol for medical abortion: a systematic review","volume":"126","author":"Chen","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2019.05.006_bb0025","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2471\/BLT.10.084046","article-title":"Comparative effectiveness, safety and acceptability of medical abortion at home and in a clinic: a systematic review","volume":"89","author":"Ngo","year":"2011","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.contraception.2019.05.006_bb0030","unstructured":"Termination of pregnancy statistics, year ending december 2016. National Services Scotland, 30 May 2017. Available at: http:\/\/www.isdscotland.org\/Health-Topics\/Sexual-Health\/Publications\/2017-05-30\/2017-05-30-Terminations-2016-Report.pdf. Accessed January 22, 2019."},{"key":"10.1016\/j.contraception.2019.05.006_bb0035","unstructured":"Abortion statistics, England and Wales: 2017. Department of Health & Social Care, December 2018. Available at: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/714183\/2017_Abortion_Statistics_Commentary.pdf. Accessed January 22, 2019."},{"key":"10.1016\/j.contraception.2019.05.006_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1363\/psrh.12015","article-title":"Abortion incidence and service availability in the United States, 2014","volume":"49","author":"Jones","year":"2017","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.contraception.2019.05.006_bb0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/13625187.2011.555568","article-title":"Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Cura\u00e7ao","volume":"16","author":"Boersma","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2019.05.006_bb0050","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0b013e31826c315f","article-title":"Extending outpatient medical abortion services through 70 days of gestational age","volume":"120","author":"Winikoff","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2019.05.006_bb0055","series-title":"Danco Laboratories","author":"Mifeprex\u00ae prescribing information","year":"2016"},{"key":"10.1016\/j.contraception.2019.05.006_bb0060","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.contraception.2013.10.018","article-title":"A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial","volume":"89","author":"Bracken","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2019.05.006_bb0065","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1471-0528.1999.tb08320.x","article-title":"Medical termination of pregnancy at 63 to 83 days gestation","volume":"106","author":"Gouk","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2019.05.006_bb0070","unstructured":"Royal College of Obstetricians and Gynaecologists. The care of women requesting induced abortion: green-top guideline no. 7. RCOG: 2011."},{"key":"10.1016\/j.contraception.2019.05.006_bb0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1148\/radiology.182.2.1732970","article-title":"Fetal crown-rump length: reevaluation of relation to menstrual age (5-18 weeks) with high-resolution real-time US","volume":"182","author":"Hadlock","year":"1992","journal-title":"Radiology"},{"key":"10.1016\/j.contraception.2019.05.006_bb0080","unstructured":"Abortion Act 1967. Available at: https:\/\/www.legislation.gov.uk\/ukpga\/1967\/87\/contents Accessed January 22, 2019."},{"key":"10.1016\/j.contraception.2019.05.006_bb0085","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.contraception.2014.09.009","article-title":"Can women determine the success of early medical termination of pregnancy themselves?","volume":"91","author":"Cameron","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2019.05.006_bb0090","first-page":"75","article-title":"Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City","volume":"44","author":"Smith","year":"2015","journal-title":"Reprod Health Matters"},{"key":"10.1016\/j.contraception.2019.05.006_bb0095","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/AOG.0000000000000603","article-title":"Incidence of emergency department visits and complications after abortion","volume":"125","author":"Upadhyay","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2019.05.006_bb0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.contraception.2014.03.016","article-title":"RU OK? The acceptability and feasibility of remote technologies for follow-up after early medical abortion","volume":"90","author":"Bracken","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2019.05.006_bb0105","unstructured":"Scottish Government Chief Medical Officer Directorate. The Abortion Act 1967 (approval of place for treatment for the termination of pregnancy) (Scotland), October 26, 2017. Available at https:\/\/www.sehd.scot.nhs.uk\/cmo\/CMO(2017)14.pdf. [Accessed January 22, 2019]."},{"key":"10.1016\/j.contraception.2019.05.006_bb0110","unstructured":"United Kingdom Department of Health & Social Care. The Abortion Act 1967 \u2014 approval of a class of places, December 27, 2018. Available at: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/768059\/Approval_of_home_use_for_the_second_stage_of_early_medical_abortion.pdf. [Accessed January 22, 2019]."},{"key":"10.1016\/j.contraception.2019.05.006_bb0115","first-page":"2018","volume":"20","author":"The Abortion Act 1967 (approval of place for treatment for the termination of pregnancy) (Wales)","year":"2018","journal-title":"June"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782419301696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782419301696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:14:48Z","timestamp":1757880888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782419301696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0010782419301696"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2019.05.006","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical abortion with mifepristone and vaginal misoprostol between 64 and 70\u202fdays' gestation","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2019.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}